<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/086/SRR25866386/SRR25866386_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/087/SRR25866387/SRR25866387_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/087/SRR25866387/SRR25866387_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/086/SRR25866386/SRR25866386_1.fastq.gz</Fastqsanger.gz></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>Fudan University Shanghai Cancer Centre</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA1011273</full_dataset_link><long_description>Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinoma</long_description><repository>ENA</repository></additional><is_claimable>false</is_claimable><name></name><description>Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinoma</description><dates><last_updated>2023-09-02</last_updated><first_public>2023-09-02</first_public></dates><accession>PRJNA1011273</accession><cross_references/></HashMap>